These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32588036)

  • 1. Applying machine learning to detect early stages of cardiac remodelling and dysfunction.
    Sabovčik F; Cauwenberghs N; Kouznetsov D; Haddad F; Alonso-Betanzos A; Vens C; Kuznetsova T
    Eur Heart J Cardiovasc Imaging; 2021 Sep; 22(10):1208-1217. PubMed ID: 32588036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular diastolic dysfunction in essential hypertension.
    Avdić S; Mujcinović Z; Asćerić M; Nukić S; Kusljugić Z; Smajić E; Arapcić S
    Bosn J Basic Med Sci; 2007 Feb; 7(1):15-20. PubMed ID: 17489762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An effect of left ventricular hypertrophy on mild-to-moderate left ventricular diastolic dysfunction.
    Kattel S; Memon S; Saito K; Narula J; Saito Y
    Hellenic J Cardiol; 2016; 57(2):92-8. PubMed ID: 27445022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of cardiomyocyte injury and stress identify left atrial and left ventricular remodelling and dysfunction: A population-based study.
    Ravassa S; Kuznetsova T; Varo N; Thijs L; Delles C; Dominiczak A; Díez J; Staessen JA
    Int J Cardiol; 2015 Apr; 185():177-85. PubMed ID: 25796005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study.
    Kim JY; Lee Y; Kang HG; Ha IS; Cheong HI; Choi HJ; Han KH; Kim SH; Cho MH; Shin JI; Lee JH; Park YS; Cho H
    BMC Nephrol; 2020 Dec; 21(1):533. PubMed ID: 33297989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum uric acid and left ventricular hypertrophy/left ventricular diastolic dysfunction in patients with chronic kidney disease.
    Kim IY; Ye BM; Kim MJ; Kim SR; Lee DW; Kim HJ; Rhee H; Song SH; Seong EY; Lee SB
    PLoS One; 2021; 16(5):e0251333. PubMed ID: 33956863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning versus classical electrocardiographic criteria for echocardiographic left ventricular hypertrophy in a pre-participation cohort.
    Lim DY; Sng G; Ho WH; Hankun W; Sia CH; Lee JS; Shen X; Tan BY; Lee EC; Dalakoti M; Kang Jie W; Kwan CK; Chow W; San Tan R; Lam CS; Chua TS; Joo Yeo T; Chong DT
    Kardiol Pol; 2021; 79(6):654-661. PubMed ID: 33885269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma neutrophil gelatinase-associated lipocalin is independently associated with left ventricular hypertrophy and diastolic dysfunction in patients with chronic kidney disease.
    Kim IY; Kim JH; Kim MJ; Lee DW; Hwang CG; Han M; Rhee H; Song SH; Seong EY; Lee SB
    PLoS One; 2018; 13(10):e0205848. PubMed ID: 30325973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular mass, geometry and function in diabetic patients affected by coronary artery disease.
    Maiello M; Zito A; Carbonara S; Ciccone MM; Palmiero P
    J Diabetes Complications; 2017 Oct; 31(10):1533-1537. PubMed ID: 28890308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D echocardiography: "The most powerful predictor of masked CVD in metabolic syndrome".
    Chopra HK; Aggarwal KK; Krishna CK; Sambi RS; Parashar SK; Gupta R; Kasliwal RR; Mittal S; Bansal M; Gaur AK; Anand V; Bali AK; Langer V; Vermani A; Jagadeesh KN; Mishra S; Nanda NC
    Indian Heart J; 2009; 61(3):231-41. PubMed ID: 20503826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of left ventricular structural and functional abnormalities with aortic and brachial blood pressure variability in hypertensive patients: the SAFAR study.
    Chi C; Yu SK; Auckle R; Argyris AA; Nasothimiou E; Tountas C; Aissopou E; Blacher J; Safar ME; Sfikakis PP; Zhang Y; Protogerou AD
    J Hum Hypertens; 2017 Oct; 31(10):633-639. PubMed ID: 28569260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and determinants of left ventricular hypertrophy and remodelling patterns in hypertensive patients: the St. Petersburg study.
    Conrady AO; Rudomanov OG; Zaharov DV; Krutikov AN; Vahrameeva NV; Yakovleva OI; Alexeeva NP; Shlyakhto EV
    Blood Press; 2004; 13(2):101-9. PubMed ID: 15182113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Grade Albuminuria Is Associated with Left Ventricular Hypertrophy and Diastolic Dysfunction in Patients with Hypertension.
    Wang T; Zhong H; Lian G; Cai X; Gong J; Ye C; Xie L
    Kidney Blood Press Res; 2019; 44(4):590-603. PubMed ID: 31387099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of left ventricular diastolic dysfunction in hypertensive patients.
    Nazário Leão R; Marques da Silva P; Marques Pocinho R; Alves M; Virella D; Palma Dos Reis R
    Hipertens Riesgo Vasc; 2018; 35(4):160-168. PubMed ID: 29398513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects.
    Milwidsky A; Maor E; Kivity S; Berkovitch A; Zekry SB; Tenenbaum A; Fisman EZ; Erez A; Segev S; Sidi Y; Goldenberg I; Kuperstein R
    Cardiovasc Diabetol; 2015 Sep; 14():119. PubMed ID: 26369690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine Learning of ECG Waveforms to Improve Selection for Testing for Asymptomatic Left Ventricular Dysfunction.
    Potter EL; Rodrigues CHM; Ascher DB; Abhayaratna WP; Sengupta PP; Marwick TH
    JACC Cardiovasc Imaging; 2021 Oct; 14(10):1904-1915. PubMed ID: 34147443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between High-Sensitivity Cardiac Troponin T and Echocardiographic Parameters in Chronic Kidney Disease: Results From the KNOW-CKD Cohort Study.
    Kang E; Ryu H; Kim J; Lee J; Lee KB; Chae DW; Sung SA; Kim SW; Ahn C; Oh KH
    J Am Heart Assoc; 2019 Sep; 8(18):e013357. PubMed ID: 31514574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.